The human microbiome in space: parallels between Earth-based dysbiosis, implications for long-duration spaceflight, and possible mitigation strategies.

Christopher E Mason, Sofia Etlin, Julianna Rose, Luca Bielski, Claire Walter, Ashley S Kleinman

Journal: Clinical microbiology reviews 2024;37(3):e0016322

PMID: 39136453

Abstract

SUMMARYThe human microbiota encompasses the diverse communities of microorganisms that reside in, on, and around various parts of the human body, such as the skin, nasal passages, and gastrointestinal tract. Although research is ongoing, it is well established that the microbiota exert a substantial influence on the body through the production and modification of metabolites and small molecules. Disruptions in the composition of the microbiota-dysbiosis-have also been linked to various negative health outcomes. As humans embark upon longer-duration space missions, it is important to understand how the conditions of space travel impact the microbiota and, consequently, astronaut health. This article will first characterize the main taxa of the human gut microbiota and their associated metabolites, before discussing potential dysbiosis and negative health consequences. It will also detail the microbial changes observed in astronauts during spaceflight, focusing on gut microbiota composition and pathogenic virulence and survival. Analysis will then turn to how astronaut health may be protected from adverse microbial changes via diet, exercise, and antibiotics before concluding with a discussion of the microbiota of spacecraft and microbial culturing methods in space. The implications of this review are critical, particularly with NASA's ongoing implementation of the Moon to Mars Architecture, which will include weeks or months of living in space and new habitats.

Address: Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.; Department of Biology, Cornell University, Ithaca, New York, USA.; BioAstra Inc., New York, New York, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.; Department of Biology, Cornell University, Ithaca, New York, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA.; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.; BioAstra Inc., New York, New York, USA.; The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, Weill Cornell Medicine, New York, New York, USA.; The Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, New York, USA.; Tri-Institutional Biology and Medicine program, Weill Cornell Medicine, New York, New York, USA.; WorldQuant Initiative for Quantitative Prediction, Weill Cornell Medicine, New York, New York, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.